Skip to main content
OpenTrials

Clinical trial condition

Amyotrophic Lateral Sclerosis (ALS)

Explore clinical trials studying Amyotrophic Lateral Sclerosis (ALS). Study availability and eligibility vary by location and protocol.

104 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis (ALS) trial results

Not yet recruiting

A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS

NCT07169175

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Not yet recruiting

Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

NCT06973629

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 15 locations
View Trial Details
Not yet recruiting

Safety Study of XT-150 in Participants With ALS

NCT06704347

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Barrow Neurological Institute (St. Joseph's) Phoenix, Arizona, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Health Detroit, Michigan, United States
View Trial Details
Not yet recruiting

An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis

NCT06645197

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fujian, Fuzhou, China
  • JiangSu Provincce Hospital Nanjing, Jiangsu, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
View Trial Details

Related conditions